India has taken an important step towards strengthening its poultry disease prevention system with the launch of its first indigenous vaccine against the H5N1 bird flu virus in chickens.
The vaccine was developed by scientists at the ICAR-National Institute of High Security Animal Diseases (ICAR-NIHSAD) in Bhopal. Union Agriculture Minister Shivraj Singh Chouhan dedicated the vaccine to the nation.
The development is expected to strengthen India’s ability to control bird flu outbreaks and reduce the financial burden on poultry farmers.
What Makes This Vaccine Important?
The newly developed inactivated vaccine specifically targets the H5N1 Highly Pathogenic Avian Influenza virus belonging to Clade 2.3.2.1a.
This strain has been responsible for many bird flu outbreaks among chickens in India. Until now, a specific commercial vaccine against this strain was not available in the country.
Why India Needs Better Bird Flu Protection
Bird flu outbreaks can spread rapidly among poultry populations, causing major losses for farmers.
Since the disease was first detected in India in 2006, the country has reported more than 500 combined outbreaks involving H5N1 and H5N8.
The 2006 outbreak alone caused estimated direct and indirect financial losses of ₹2,200–3,000 crore.
The virus is also a public health concern because certain strains can infect humans and other animals.
Will This Vaccine Protect Humans?
The newly developed vaccine is specifically intended for chickens, not humans. It is designed to help control the targeted H5N1 strain in poultry and reduce the risk of its spread.
Details about commercial availability, pricing and vaccination schedules have not yet been established in the available announcement.
The development marks an important milestone in India’s animal disease research and poultry health preparedness.
